The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Open accessAbstract
Our understanding of Alzheimer's disease pathogenesis is currently limited by difficulties in obtaining live neurons from patients and the inability to model the sporadic form of the disease. It may be possible to overcome these challenges by reprogramming primary cells from patients into induced pluripotent stem cells (iPSCs). Here we reprogrammed primary fibroblasts from two patients with familial Alzheimer's disease, both caused by a duplication of the amyloid-β precursor protein gene (APP; termed APP(Dp)), two with sporadic Alzheimer's disease (termed sAD1, sAD2) and two non-demented control individuals into iPSC lines. Neurons from differentiated cultures were purified with fluorescence-activated cell sorting and characterized. Purified cultures contained more than 90% neurons, clustered with fetal brain messenger RNA samples by microarray criteria, and could form functional synaptic contacts. Virtually all cells exhibited normal electrophysiological activity. Relative to controls, iPSC-derived, purified neurons from the two APP(Dp) patients and patient sAD2 exhibited significantly higher levels of the pathological markers amyloid-β(1-40), phospho-tau(Thr 231) and active glycogen synthase kinase-3β (aGSK-3β). Neurons from APP(Dp) and sAD2 patients also accumulated large RAB5-positive early endosomes compared to controls. Treatment of purified neurons with β-secretase inhibitors, but not γ-secretase inhibitors, caused significant reductions in phospho-Tau(Thr 231) and aGSK-3β levels. These results suggest a direct relationship between APP proteolytic processing, but not amyloid-β, in GSK-3β activation and tau phosphorylation in human neurons. Additionally, we observed that neurons with the genome of one sAD patient exhibited the phenotypes seen in familial Alzheimer's disease samples. More generally, we demonstrate that iPSC technology can be used to observe phenotypes relevant to Alzheimer's disease, even though it can take decades for overt disease to manifest in patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“iPSC-derived neurons from individuals with AD exhibit increased production of Aβ42, active GSK-3β, phosphorylated tau, endosomal abnormalities, and oxidative stress (12–17)”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“but late-stage neuropathological features, such as formation of insoluble tau and neurodegeneration have not been reported.”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Accumulation of pTau in FAD neurons can be reversed by inhibition of β-secretase, the enzyme that converts APP to β-CTF indicating a direct relationship between APP processing and Tau (Israel et al., 2012, Moore et al., 2015).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Israel et al., 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In iPSC-derived neurons from both FAD- and SAD-patients, pTau aberrantly accumulates at early time points (Choi et al., 2014, Israel et al., 2012, Moore et al., 2015, Muratore et al., 2014, Ochalek et al., 2017, Shi et al., 2012).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Israel et al., 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, neuronal endosomal swelling has been classed as an early hallmark of Alzheimer's disease indicative of a perturbation in endosomal cargo sorting [8,9,56].”
From Global identification of neuronal and astrocytic integral membrane proteins that require Retromer for their endosomal recycling (2026) · cites this paper as [56]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, inhibition of γ-secretase (to prevent generation of Aβ from β-CTF) did not reduce pTau, indicating that the effect of APP processing on pTau in early AD neurons is not solely mediated by extracellular Aβ (Israel et al., 2012, Moore et al., 2015).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Israel et al., 2012
The cited source says what the claim attributes to it.
In the citing paper
“pThr231Tau accumulates in APP duplication (APPdp) iPSC-derived FAD neurons (Israel et al., 2012).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Israel et al., 2012
In the citing paper
“Several studies related to neurological disease successfully reverted a disease-associated cellular phenotype in patient-derived cells by correcting the disease-associated mutation, for example in the MAPT gene106,107.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [106]
In the citing paper
“Multiple groups have characterized iPSC lines from donor cells from FAD and sAD patients, which show increased production of Aβ, particularly Aβ42, and tau hyperphosphorylation in comparison to iPSCs derived from age-matched non-demented controls [66, 82, 101, 175].”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [66]
In the citing paper
“Some iPSC lines also have evidence of additional AD-associated pathology such as increased activation of GSK3β [66], increased number of large endosomes [66], and accumulation of intraneuronal Aβ oligomers [82].”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Liang, Q., Fujita, R., Yamashita, T., Angulo, S. L., Rhinn, H., Rhee, D. B., Doege, C. A., Chau, L., Aubry, L., Vanti, W. B., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.007 · Cited by 231
RetractedInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Role of Genes and Environments for Explaining Alzheimer Disease
Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798
Cited by
Sorted by citations
Items 801–900 of 1,002
Srinivasan, G. R., & Brafman, D. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.813544 · Cited by 10
Hasan, M. F., & Trushina, E. V. (2022) · Brain Sciences · doi:10.3390/brainsci12050552 · Cited by 10
Young, J. E., & Goldstein, L. S. B. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2655-9_6 · Cited by 10
Self-citationResearch progress in animal models and stem cell therapy for Alzheimer’s disease
Han, F., Wang, W., & Chen, C. (2014) · Journal of Neurorestoratology · doi:10.2147/jn.s74160 · Cited by 11
Induced Pluripotent Stem Cell-Based Studies of Parkinson's Disease: Challenges and Promises
Sánchez‐Danés, A., Benzoni, P., Memo, M., Dell`Era, P., Raya, Á., & Consiglio, A. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152731131200128 · Cited by 11
Nižetić, D., Chen, C., Hong, W., & Koo, E. H. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00299 · Cited by 9
Self-citationYang, D., Zhu, L., Ren, J., Ma, R., Zhu, H., & Xu, J. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-015-1541-9 · Cited by 10
Stepping back to move forward: a current review of iPSCs in the fight against Alzheimer's disease.
Devineni, A., Tohme, S., Mt, K., Cowley, R. A., & Harris, B. T. (2016) · Europe PMC (PubMed Central) · Cited by 10
Langlie, J. A., Mittal, R., Finberg, A., Bencie, N. B., Mittal, J., Omidian, H., Omidi, Y., & Eshraghi, A. A. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335836 · Cited by 10
Human Stem Cells for Craniomaxillofacial Reconstruction
Jalali, M., Kirkpatrick, W. N. A., Cameron, M. G., Pauklin, S., & Vallier, L. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0576 · Cited by 10
Developmental anatomy of the primary olfactory pathway in the opossum Monodelphis domestica.
Chuah, M. I., Tennent, R., & Teague, R. (1997) · PubMed · Cited by 10
Supakul, S., Oyama, C., Hatakeyama, Y., Maeda, S., & Okano, H. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2023.12.018 · Cited by 10
Adak, S., Singh, S., Jain, R., Tiwari, A., Singh, B., Kumar, S., Dadhwal, A., Chakroborty, A., Sharma, A. K., Singh, R. P., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1646551 · Cited by 12
Induced Pluripotency for Translational Research
Wu, M., Chen, G., & Hu, B. (2013) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2013.08.001 · Cited by 9
Kiris, E. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_683 · Cited by 9
Building in vitro models of the brain to understand the role ofAPOEin Alzheimer’s disease
Pinals, R. L., & Tsai, L. (2022) · Life Science Alliance · doi:10.26508/lsa.202201542 · Cited by 10
Ohno, M. (2023) · Frontiers in Dementia · doi:10.3389/frdem.2023.1161875 · Cited by 10
Proceedings: Cell Therapies for Parkinson's Disease From Discovery to Clinic
Canet-Aviles, R., Lomax, G. P., Feigal, E. G., & Priest, C. A. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0146 · Cited by 9
The utility of stem cells for neural regeneration
Goncalves, K., & Przyborski, S. A. (2018) · Brain and Neuroscience Advances · doi:10.1177/2398212818818071 · Cited by 10
Zhang, Y., Hu, W., Ma, K., Zhang, C., & Fu, X. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09900-8 · Cited by 11
Liu, Y., & Wang, H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190614 · Cited by 9
Argentati, C., Tortorella, I., Bazzucchi, M., Emiliani, C., Morena, F., & Martino, S. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030115 · Cited by 10
Patient-derived iPSCs, a reliable in vitro model for the investigation of Alzheimer’s disease
Asiamah, E. A., Guo, R., Kong, D., Feng, B., He, J., Zhang, W., Liu, X., Du, X., Ma, Z., Liu, B., et al. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0065 · Cited by 9
Lee, J., Yoo, G., Choi, J., Park, S.-H., Shin, H., Prasad, R., Lee, Y., Ahn, M. R., Cho, I., & Sun, W. (2022) · Molecular Brain · doi:10.1186/s13041-022-00928-5 · Cited by 9
Orr, M. E., Pitstick, R., Canine, B., Ashe, K. H., & Carlson, G. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039328 · Cited by 9
Modelling neurodegenerative diseases in vitro: Recent advances in 3D iPSC technologies
Siney, E. J., Kurbatskaya, K., Chatterjee, S., Prasannan, P., Mudher, A. K., & Willaime‐Morawek, S. (2018) · AIMS Cell and Tissue Engineering · doi:10.3934/celltissue.2018.1.1 · Cited by 9
Jendelová, P., Syková, E., & Erceg, S. (2018) · Results and problems in cell differentiation · doi:10.1007/978-3-319-93485-3_3 · Cited by 9
Neural Progenitor Cell Derivation Methodologies for Drug Discovery Applications
Porterfield, V. M. (2019) · Assay and Drug Development Technologies · doi:10.1089/adt.2019.921 · Cited by 9
A Human Embryonic Stem Cell Model of Aβ-Dependent Chronic Progressive Neurodegeneration
Ubina, T., Magallanes, M., Srivastava, S., Warden, C., Yee, J., & Salvaterra, P. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01007 · Cited by 9
Atkinson-Dell, R., & Mohamet, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9913-8_15 · Cited by 10
Tang, Y., Han, Y., Yu, H., Zhang, B., & Li, G. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135208 · Cited by 9
Weick, J. P., Kang, H., Bonadurer, G. F., & Bhattacharyya, A. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_15 · Cited by 9
Alzheimer’s Disease and Dementia
Lewis, P. A., & Spillane, J. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811069-0.00002-1 · Cited by 9
Chandrashekar, H., Simándi, Z., Choi, H., Ryu, H.-S., Waldman, A. J., Nikish, A., Muppidi, S. S., Gong, W., Paquet, D., & Phillips‐Cremins, J. E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.27.582395 · Cited by 10
Zhou, X., Du, K., Mao, T., Wang, N., Zhang, L., Tian, Y., Liu, T., Wang, L., & Wang, X. (2024) · iScience · doi:10.1016/j.isci.2024.111413 · Cited by 8
Changes in iPSC-astrocyte morphology reflect Alzheimer’s disease patient clinical markers
Rowland, H. A., Miller, G., Liu, Q., Li, S., Sharp, N. R., Ng, B., Wei, L., Arunasalam, K., Koychev, I. G., Hedegaard, A., et al. (2024) · Stem Cells · doi:10.1093/stmcls/sxae085 · Cited by 8
Labra, S. R., Compher, J., Prabhavalkar, A., Almaraz, M., Kwong, C. C., Baal, C., Talantova, M. V., Dolatabadi, N., Piña‐Sanz, J., Wang, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.202514783 · Cited by 9
Cortical Differentiation of Human Pluripotent Cells for In Vitro Modeling of Alzheimer’s Disease
Saurat, N. G., Livesey, F. J., & Moore, S. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_16 · Cited by 8
GABAergic signaling abnormalities in a novel CLU mutation Alzheimer's disease mouse model
Chen, C., Tang, X., Lan, Z., Wan, C., Su, H., Li, W., Li, Y., Zhou, X. W., Gao, H., Feng, X., et al. (2023) · Translational research · doi:10.1016/j.trsl.2023.05.003 · Cited by 8
A narrative review of organoids for investigating organ aging: opportunities and challenges
Sun, X., Sun, F., Zhang, Y., Qu, J. T., Zhang, W., & Liu, G. (2023) · Journal of Bio-X Research · doi:10.1097/jbr.0000000000000139 · Cited by 8
Human-Derived Neurons and Neural Progenitor Cells in High Content Imaging Applications
Harrill, J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7357-6_18 · Cited by 9
Cellular reprogramming: A new way to understand aging mechanisms
İlçe, B. Y., Cagin, U., & Yılmazer, A. (2018) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.308 · Cited by 8
Your brain under the microscope: the promise of stem cells.
Marchetto, M. C., & Gage, F. H. (2014) · Europe PMC (PubMed Central) · Cited by 8
Self-citationMesa, H., Zhang, E. Y., Wang, Y., & Zhang, Q. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.30999 · Cited by 9
Cifelli, J. L., Berg, K. R., & Yang, J. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12788 · Cited by 8
Skin Mirrors Brain: A Chance for Alzheimer’s Disease Research
Zouboulis, C. C., Makrantonaki, E., & Hossini, A. M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-78787-5_45 · Cited by 8
Generating Induced Pluripotent Stem Cells for Multiple Sclerosis Therapy
Fossati, V., & Douvaras, P. (2014) · Regenerative Medicine · doi:10.2217/rme.14.63 · Cited by 9
Kazemi, M., Sanati, M., Khaniani, M. S., & Ghafouri‐Fard, S. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149595 · Cited by 8
Varghese, N., Szabo, L., Cader, M. Z., Lejri, I., Grimm, A., & Eckert, A. (2025) · Communications Biology · doi:10.1038/s42003-025-08152-2 · Cited by 17
An overview of in vitro research models for Alzheimer`s disease (AD)
Ntimi, C. M., Rosli, R., Adam, A., & Nordin, N. (2013) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia) · Cited by 7
Isolation, identification and differentiation of human embryonic cartilage stem cells
Fu, C., Yan, Z., Xu, H. Y., Zhang, C., Zhang, Q., Wei, A., Yang, X., & Wang, Y. (2015) · Cell Biology International · doi:10.1002/cbin.10434 · Cited by 7
Reprint of “iPSCs, aging and age-related diseases”
Isobe, K., Cheng, Z., Nishio, N., Suganya, T., Tanaka, Y., & Ito, S. (2014) · New Biotechnology · doi:10.1016/j.nbt.2014.11.002 · Cited by 7
Phenotypic Assays for β-Amyloid in Mouse Embryonic Stem Cell-Derived Neurons
McIntire, L. B., Landman, N., Kang, M. S., Finan, G. M., Hwang, J. C., Moore, A. Z., Park, L., Lin, C., & Kim, T. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.06.005 · Cited by 7
Jung‐Klawitter, S., & Opladen, T. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0225-9 · Cited by 8
Becklin, K. L., Draper, G. M., Madden, R. A., Kluesner, M. G., Koga, T., Huang, M., Weiss, W. A., Spector, L. G., Largaespada, D. A., Moriarity, B. S., et al. (2022) · The CRISPR Journal · doi:10.1089/crispr.2022.0032 · Cited by 7
Wenker, S. D., Casalia, M. L., Candedo, V. C., Casabona, J. C., & Pitossi, F. J. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.07.023 · Cited by 7
Stem cell reprogramming: Basic implications and future perspective for movement disorders
Brändl, B., Schneider, S. A., Loring, J. F., Hardy, J., Gribbon, P. M., & Müller, F. (2014) · Movement Disorders · doi:10.1002/mds.26113 · Cited by 8
Extracellular Matrix Enhances Therapeutic Effects of Stem Cells in Regenerative Medicine
Nie, Y., Zhang, S., Liu, N., & Li, Z. (2016) · InTech eBooks · doi:10.5772/62229 · Cited by 7
Robin, G., Evans, J. C., Hauser, D. N., Wren, P. B., & Zembrzycki, A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.576678 · Cited by 7
Imaging organelle transport in primary hippocampal neurons treated with amyloid-β oligomers
Gan, K. J., & Silverman, M. A. (2015) · Methods in cell biology · doi:10.1016/bs.mcb.2015.06.012 · Cited by 7
Spatiotemporal Complexity of Fibroblast Networks Screens for Alzheimer's Disease
Chirila, F. V., Khan, T. K., & Alkon, D. L. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120745 · Cited by 8
Digwal, C. S., Sharma, S., Santhaseela, A. R., Ginsberg, S. D., & Chiosis, G. (2022) · Wiley eBooks · doi:10.1002/9781119774198.ch1 · Cited by 7
Human iPSC Models in Drug Discovery: Opportunities and Challenges
Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J. (2017) · Comprehensive Medicinal Chemistry III · doi:10.1016/b978-0-12-409547-2.12284-x · Cited by 6
Fourrière, L., & Gleeson, P. A. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1550211 · Cited by 6
In vitro technology and ADMET research in traditional Chinese medicine
Xue, J., Gao, S., You, Z., Xu, S., Zhou, J., Jiang, H., & Liu, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1605330 · Cited by 7
Rose, S. E., Williams, C. A., Hailey, D. W., Mishra, S., Kirkland, A., Keene, C. D., Garden, G. A., Jayadev, S., & Young, J. E. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1321680 · Cited by 6
Vigier, M., Uriot, M., Djelti, F., Claudepierre, T., Hajj, A. E., Yen, F. T., Oster, T., & Malaplate, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136816 · Cited by 6
Christian, K. M., Song, H., & Ming, G. (2012) · Frontiers in Biology · doi:10.1007/s11515-012-1216-0 · Cited by 7
Functional genomics, genetic risk profiling and cell phenotypes in neurodegenerative disease
Finkbeiner, S. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105088 · Cited by 8
Behl, T., Kaur, I., Sehgal, A., Singh, S., Sharma, N., Chigurupati, S., Felemban, S. G., Alsubaiyel, A. M., Iqbal, M. S., Bhatia, S., et al. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10390-4 · Cited by 6
Inflammation-Mediated Responses in the Development of Neurodegenerative Diseases
Nainu, F., Mamada, S. S., Harapan, H., & Emran, T. B. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_3 · Cited by 6
Genetic approach to track neural cell fate decisions using human embryonic stem cells
Fu, X., Rong, Z., Zhu, S., Wang, X., Xu, Y., & Lake, B. B. (2014) · Protein & Cell · doi:10.1007/s13238-013-0007-y · Cited by 6
Hunter, S., & Brayne, C. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.015 · Cited by 6
Salem, H., Rocha, N. P., Colpo, G. D., & Teixeira, A. L. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160250 · Cited by 6
Modeling neurodegenerative disorders in adult somatic cells: A critical review
Truong, A. N., Si, E., Duncan, T., & Valenzuela, M. (2016) · Frontiers in Biology · doi:10.1007/s11515-016-1413-3 · Cited by 6
Induced Pluripotent Stem Cells (iPSCs) in Developmental Toxicology
Easley, C. A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9182-2_3 · Cited by 5
Genome editing in stem cells for genetic neurodisorders
Dell’Amico, C., Tata, A., Pellegrino, E., Onorati, M., & Conti, L. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.12.006 · Cited by 6
The Potential of Induced Pluripotent Stem Cells to Treat and Model Alzheimer’s Disease
Schulz, J. M. (2021) · Stem Cells International · doi:10.1155/2021/5511630 · Cited by 6
Brain aging, Alzheimer's disease, and the role of stem cells in primate comparative studies
August, I., Semendeferi, K., & Marchetto, M. C. (2022) · The Journal of Comparative Neurology · doi:10.1002/cne.25394 · Cited by 6
Reprogramming neurodegeneration in the big data era
Zhou, L., & Verstreken, P. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.12.015 · Cited by 6
Romero, I. G., Pavlovic, B. J., Hernando-Herraez, I., Banovich, N. E., Kagan, C. L., Burnett, J. E., Huang, C. H., Mitrano, A., Chavarria, C. I., Ben‐Nun, I. F., et al. (2014) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/008862 · Cited by 6
Self-citationCRISPR-activated patient fibroblasts for modeling of familial Alzheimer's disease
Inoue, K. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.03.008 · Cited by 4
iPSCs-Derived Neurons and Brain Organoids from Patients
Zhu, W., Xu, L., Li, X., Hu, H., Lou, S.-N., & Liu, Y. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_657 · Cited by 5
Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency
Bekas, N., Samiotaki, M. K., Papathanasiou, M., Mokos, P., Pseftogas, A., Xanthopoulos, K., Thanos, D., Mosialos, G., & Dafou, D. (2023) · Cancers · doi:10.3390/cancers15204997 · Cited by 4
Qin, S.-J., Zeng, Q.-G., Zeng, H.-X., Zeng, H.-X., Wu, Q.-Z., Lv, Y., Dai, J., Dong, G., & Zeng, X. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2024.125601 · Cited by 6
From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer’s Disease Landscape
Bougea, A. M., Debasa‐Mouce, M., Gulkarov, S., Castro‐Mosquera, M., Reiss, A. B., & Ouro, A. (2025) · Medicina · doi:10.3390/medicina61081462 · Cited by 5
The deubiquitinase OTULIN regulates tau expression and RNA metabolism in neurons
Tangavelou, K., Bondu, V., Li, M., Li, W., Liao, F., & Bhaskar, K. (2025) · Genomic psychiatry : · doi:10.61373/gp025a.0116 · Cited by 5
Using Induced Pluripotent Stem Cells to Model Neurodegenerative Diseases
Gu, H. (2013) · Journal of Ancient Diseases & Preventive Remedies · doi:10.4172/2329-8731.1000e101 · Cited by 5
Tissue engineered organoids for neural network modelling
Roach, P., Köse-Dunn, M. J., & Fricker, R. A. (2017) · Advances in Tissue Engineering & Regenerative Medicine Open Access · doi:10.15406/atroa.2017.03.00066 · Cited by 5
Goldstein, L. S. B., & Das, U. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.001 · Cited by 5
Self-citationHuman Brain Banking as a Convergence Platform of Neuroscience and Neuropsychiatric Research
Liu, F., Yin, X., Cong, C., Wang, Y., & Ma, C. (2022) · Human Brain · doi:10.37819/hb.001.001.0204 · Cited by 5
McCaughey‐Chapman, A., Tarczyluk, M. A., Combrinck, C., Edwards, N., Jones, K., & Connor, B. J. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1003188 · Cited by 7
Shigyo, M., Kobayashi, Y., Platoshyn, O., Marsala, S., Kato, T., Takamura, N., Yoshida, K., Kishino, A., Bravo‐Hernández, M., Juhás, Š., et al. (2023) · Cell Transplantation · doi:10.1177/09636897231163232 · Cited by 5
Systems Medicine as a Strategy to Deal with Alzheimer’s Disease
Zeng, X. X., & Zeng, J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230739 · Cited by 5
Ohno, M. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231451 · Cited by 5
Converted neural cells: induced to a cure?
Zhang, W., Duan, S., Li, Y., Xu, X., Qu, J., Zhang, W., & Liu, G.-H. (2012) · Protein & Cell · doi:10.1007/s13238-012-2029-2 · Cited by 4
Capillary electrophoresis of induced pluripotent stem cells during differentiation toward neurons
Wang, C., & Kuo, Y. (2014) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2014.06.022 · Cited by 5
Genetic strategies to investigate neuronal circuit properties using stem cell-derived neurons
Garcia, I., Kim, C., & Arenkiel, B. R. (2012) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2012.00059 · Cited by 5
Stem cell models of Alzheimer's disease and related neurological disorders
Livesey, F. J. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt147 · Cited by 5
Induced Pluripotent Stem Cells as a Novel Tool in Psychiatric Research
Kim, S., Kim, M., Oh, D., Lee, S., & Kim, B. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.1.8 · Cited by 5
Metadata
- Authors
- Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., Carson, C. T., Laurent, L. C., Marsala, M., Gage, F. H., Remes, A. M., Koo, E. H., & Goldstein, L. S. B.
- Affiliations
- Howard Hughes Medical Institute (US)
- Salk Institute for Biological Studies (US)
- University of California San Diego (US)
- Scripps Research Institute (US)
- BD Biosciences (United States) (US)
- University of Oulu (FI)
- Corresponding author
- Goldstein, Lawrence S. B.
- ORCID
- Venue
- Nature
- Published
- 2012-01-25
- Volume
- 482
- Issue
- 7384
- Pages
- 216-220
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3338985
- OpenAlex
- W2088714934
- Cited by
- 1,253
- References
- 37
- Citations by year
- 2026: 45 · 2025: 55 · 2024: 73 · 2023: 61 · 2022: 100 · 2021: 73 · 2020: 105 · 2019: 86 · 2018: 87 · 2017: 76 · 2016: 108 · 2015: 105 · 2014: 106 · 2013: 95 · 2012: 74
- FWCI
- 81.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- (No Title)
- Funders
- Howard Hughes Medical Institute
- National Institute on Aging (P50AG005131)
- National Institute of General Medical Sciences (T32GM008666)
- National Institute of Neurological Disorders and Stroke (P30NS047101, RC1NS068705)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD001259)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, induced pluripotent stem cells, familial Alzheimer's disease, sporadic Alzheimer's disease, amyloid-beta secretion, gamma-secretase inhibitors, beta-secretase inhibitors, phosphorylated tau, glycogen synthase kinase-3β, APP proteolytic processing, iPSC-derived neurons, patient-derived fibroblasts
- MeSH terms
- Aged, 80 and over, Alzheimer Disease, Astrocytes, Cells, Cultured, Enzyme Activation, Female, Fibroblasts, Humans, Male, Middle Aged, Models, Biological, Neurons, Peptide Fragments, Phosphoproteins, Phosphorylation, Protease Inhibitors, Endosomes, Biomarkers, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Synapsins, tau Proteins, Coculture Techniques, Glycogen Synthase Kinase 3, Amyloid Precursor Protein Secretases, Induced Pluripotent Stem Cells, Proteolysis, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
